TABLE 1.
Baseline characteristics.
| 200 mg BID (n = 10) | 300 mg BID (n = 10) | 400 mg BID (n = 10) | 500 mg BID (n = 10) | SHR7280 total(n = 40) | Placebo (n = 8) | |
|---|---|---|---|---|---|---|
| Age, years | 32.7 ± 9.5 | 30.7 ± 9.3 | 32.7 ± 6.5 | 34.1 ± 5.5 | 32.6 ± 7.7 | 35.9 ± 3.4 |
| BMI, kg/m2 | 22.8 ± 2.4 | 23.0 ± 3.1 | 22.4 ± 3.4 | 24.0 ± 1.7 | 23.1 ± 2.7 | 24.0 ± 2.9 |
| Height, cm | 160.2 ± 6.9 | 159.3 ± 6.3 | 160.8 ± 4.0 | 160.9 ± 5.4 | 160.3 ± 5.6 | 159.4 ± 7.4 |
| Weight, kg | 58.7 ± 8.8 | 58.3 ± 6.8 | 57.9 ± 9.6 | 62.1 ± 4.1 | 59.3 ± 7.5 | 60.8 ± 7.2 |
Data are mean ± SD.